Medical Xpress August 23, 2024
Ogechi Ekeanyanwu, SciDev.Net

Artificial intelligence (AI) and traditional medicine may seem like strange bedfellows but African researchers are harnessing both to advance drug discovery on the continent.

Fidele Ntie-Kang, an associate professor of pharmaceutical chemistry at the University of Buea, Cameroon, is spearheading attempts to develop from Africa’s abundant natural biodiversity, using AI to screen hundreds of natural compounds.

In this interview with SciDev.Net, he discusses the constraints of carrying out research in Africa and how his team of researchers are overcoming these in efforts to find home-grown solutions to globally neglected diseases.

Can you tell us how you became involved in drug discovery?

Growing up in Cameroon, I frequently suffered from malaria and I vividly remember my father rushing to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Interview / Q&A, Pharma, Pharma / Biotech, Technology, Trends
Cofactor AI Nabs $4M to Combat Hospital Claim Denials with AI
Set Your Team Up to Collaborate with AI Successfully
What’s So Great About Nvidia Blackwell?
Mayo develops new AI tools
Medtronic, Tempus testing AI to find potential TAVR patients

Share This Article